Search Results for "Nipro Family Of Companies"
Original Source: Nipro Corporation
Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), founded in 1954, is engaged directly and through its subsidiaries principally in the development, manufacture and sale of medical devices, pharmaceutical products and medical and glass products. Niproâs medical device division is engaged in the manufacture and sale of medical devices and its related products, the development, manufacture and sale of cell culturing-related...
Matching Channels
B cell activating factor of the TNF family BAFF
Treatment of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis and multiple sclerosis.
After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...
The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...
In addition to the world famous Cambridge University, Cambridge and its surrounding area is a hub of globally reaching biotechnology companies. With more than 247 companies, and the high quality res...
Located in the north-east corner of the USA, Massachusetts, has the third highest GDP of any state in America and is also a hotspot for the biotechnology industry. In addition to the globally renown...
Matching News
Japan Nipro To Buy Two-Thirds Of Device-Maker Goodman For $36 Million
Japan's Nipro said it plans to buy a two-thirds stake in Goodman Co. Ltd, maker of medical equipment such as catheters, for $36 million and make it a subsidiary.
Nipro exit from troubled Bipha JV may smooth Mitsubishi Tanabe blood product rejig
The Japanese blood product operation Bipha will once again become a wholly owned subsidiary of Mitsubishi Tanabe Pharma (MTP) following a decision by long-time partner Nipro Corp to divest its inter...
Mitsubishi Tanabe to take full control of Bipha JV
Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) has agreed to acquire the 49% holding (20,580 shares) held by fellow Japan based Nipro Corp in the blood product joint venture Bipha Corp, with...
[Nipro] gets Japanese rights to [InfraReDx]'s {TVC Imaging System}
[Nipro Corp.] has licensed exclusive Japanese distribution rights to cardiovascular device developer [InfraReDx Inc.]’s {TVC Imaging System}, which helps in the diagnosis of coronary artery disease....
Nipro Diagnostics, NextGen enter agreement for TRUEresult blood glucose monitoring system
NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it...
Nipro Diagnostics, Inc. Names Dean Sorrentino as Chief Financial Officer
Nipro Diagnostics, Inc., a leading manufacturer and marketer of blood glucose monitoring products and supplies for diabetes management, today announced Dean Sorrentino has joined...
Mitsubishi Tanabe Pharma, Nipro deal
Nipro Diagnostics Introduces Extensive New Line of Ancillary Products for the Diabetes Category
Nipro Diagnostics, Inc. – a leading manufacturer and marketer of blood glucose monitoring products and diabetes management supplies – today announced that it has begun to ship...
Matching PubMed Articles
StatBite Top 10 Pharmaceutical Companies.
Companies hope for kinase inhibitor JAKpot.
Of Ephs and Ephrins: Companies Target Guidance Molecules in Cancer.
Since 2002, the Leem (French Association of Pharmaceutical Companies) has conducted a survey every two years to update the attractiveness of France for international clinical trials. Thirty compa...
